Triptorelin - Prostate cancer
You are here : Home > Formulary Search > Triptorelin - Prostate cancer
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
Guidelines (National)
Evidence Review
PAD Profile
ChemicalSubstance :
Triptorelin
Indication :
Prostate cancer
Group Name :
Keywords :
Gonaderelin Analogue, Luteinising hormone-releasing hormone, LHRH agonist
Brand Names Include :
Decapeptyl, Gonapeptyl
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
5
Other Indications
Below are listed other indications that Triptorelin is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Prostate cancer.
Committee Recommendations (1)
Following harmonisation of the licensed indications for goserelin, leuprorelin and triptorelin, it was agreed by PCN that all three drugs should be available and will be considered Amber * on the traffic light system. The choice of product should be informed by an individual patient's preferences in relation to route of administration and frequency of injections.